NCT05458648View on ClinicalTrials.gov

A Prospective Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm

Active, not recruitingOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

October 30, 2023

Study Completion Date

August 30, 2024

Conditions
Persistent Atrial FibrillationCardiac Arrhythmia
Interventions
PROCEDURE

Cardiac Ablation for the treatment of persistent Atrial Fibrillation

Patients participating in the study will undergo a cardiac ablation for the treatment of persistent atrial fibrillation.

Trial Locations (1)

10016

NYU Langone Health, New York

Sponsors

Lead Sponsor

CathVision ApS

Collaborators (1)

Medicept Inc.
All Listed Sponsors
collaborator

Medicept Inc.

INDUSTRY

lead

CathVision ApS

INDUSTRY

NCT05458648 - A Prospective Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm | Biotech Hunter | Biotech Hunter